There have been very POSITIVE clinical trials oversees (you can look it up). The US has less than 1% of the world's cases of sickle cell. The country that would benefit the most is Africa, which, I believe, has 85% of the world's cases... this is our target population right now (Nigeria in the immediate future).
And BTW, who ever said it was a cure? It's obvious that you have another agenda.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.